POLB and Alzheimer disease: Decreased levels of Polβ have been observed from the brain tissue of patients with AD (Copani et al., 2006), mild cognitive impairment (MCI) (Weissman et al., 2007), or down syndrome (Patterson and Cabelof, 2012), a genetic disorder that is reported to have an increased risk of developing AD.